Published in Can Respir J on April 18, 2011
Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study. Br J Clin Pharmacol (2015) 1.07
Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists. Can Fam Physician (2012) 0.99
Caring for the older person with chronic obstructive pulmonary disease. JAMA (2012) 0.96
Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline. Can Respir J (2012) 0.92
Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes. CMAJ Open (2013) 0.85
Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med (2015) 0.84
Reconsideration of key articles regarding medication-related problems in older adults from 2011. Am J Geriatr Pharmacother (2012) 0.81
Burning HOT: revisiting guidelines associated with home oxygen therapy. Int J Burns Trauma (2012) 0.80
Behavioral medicine approaches to chronic obstructive pulmonary disease. Ann Behav Med (2012) 0.80
Advanced Chronic Obstructive Pulmonary Disease: Innovative and Integrated Management Approaches. Chin Med J (Engl) (2015) 0.78
Chronic obstructive pulmonary disease (COPD) evidentiary framework. Ont Health Technol Assess Ser (2012) 0.78
Hospitalist attitudes toward the assessment and management of dyspnea in patients with acute cardiopulmonary diseases. J Hosp Med (2015) 0.77
A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc (2014) 0.77
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. Support Care Cancer (2015) 0.76
Academic detailing of general practitioners by a respiratory physician for diagnosis and management of refractory breathlessness: a randomised pilot study. BMC Health Serv Res (2015) 0.75
Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review. Syst Rev (2016) 0.75
Symptom management in the older adult: 2015 update. Clin Geriatr Med (2015) 0.75
[Dyspnea, itching and depression in palliative medicine]. Schmerz (2016) 0.75
Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study. Support Care Cancer (2016) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84
A new system for grading recommendations in evidence based guidelines. BMJ (2001) 11.13
AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ (2010) 8.73
Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet (1981) 6.48
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med (1980) 4.81
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
A systematic review of the use of opioids in the management of dyspnoea. Thorax (2002) 4.10
An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med (2008) 3.98
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med (1999) 3.31
Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet (2010) 3.07
Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Res Ed) (1981) 2.74
Randomised trial of ambulatory oxygen in oxygen-dependent COPD. Eur Respir J (2005) 2.42
Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ (2003) 2.40
Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev (2008) 2.38
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37
A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax (2010) 2.25
Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax (1997) 2.09
A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer. Palliat Med (2001) 2.07
Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome. Q J Med (1980) 2.01
Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med (1981) 1.94
The last year of life of COPD: a qualitative study of symptoms and services. Respir Med (2004) 1.92
Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med (2007) 1.80
Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest (2005) 1.75
Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med (2007) 1.74
Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD (2005) 1.64
Pathophysiology of dyspnea. N Engl J Med (1995) 1.61
Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc (2007) 1.56
Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med (1983) 1.55
An evaluation of the acute impact of pursed lips breathing on walking distance in nonspontaneous pursed lips breathing chronic obstructive pulmonary disease patients. Chron Respir Dis (2005) 1.53
American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest (2010) 1.46
Toward optimal end-of-life care for patients with advanced chronic obstructive pulmonary disease: insights from a multicentre study. Can Respir J (2008) 1.45
Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis (1991) 1.44
COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol Med (2007) 1.43
Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest (2006) 1.42
Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage (2011) 1.42
In-phase chest wall vibration decreases dyspnea during arm elevation in chronic obstructive pulmonary disease patients. Intern Med (1998) 1.42
Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax (2002) 1.39
Measurement of breathlessness in advanced disease: a systematic review. Respir Med (2006) 1.38
Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics (1992) 1.33
Anxiety and depression in end-stage COPD. Eur Respir J (2008) 1.32
Dihydrocodeine for breathlessness in "pink puffers". Br Med J (Clin Res Ed) (1983) 1.32
Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med (2007) 1.29
A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J (2004) 1.28
Long-term oxygen therapy improves health-related quality of life. Respir Med (2004) 1.24
Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.23
Randomised controlled trial of transcutaneous electrical muscle stimulation of the lower extremities in patients with chronic obstructive pulmonary disease. Thorax (2002) 1.19
Palliation of dyspnoea in advanced COPD: revisiting a role for opioids. Thorax (2009) 1.13
Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J (2002) 1.12
Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur Respir J (1996) 1.11
A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry (2001) 1.10
Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ (2002) 1.10
Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med (2007) 1.07
Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest (2005) 1.04
Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the "pink puffer" syndrome. Eur Respir J (1991) 1.04
Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life. Respir Med (2008) 1.03
Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. Am J Respir Crit Care Med (1995) 1.01
Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics (1998) 1.01
Mechanisms of dyspnea. Chest (2010) 1.00
The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1998) 1.00
A randomized control trial of nursing-based case management for patients with chronic obstructive pulmonary disease. Lippincotts Case Manag (2002) 1.00
The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med (2004) 1.00
Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis (2005) 0.98
Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale. A controlled double-blind crossover study. Chest (1975) 0.94
COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. Med J Aust (2006) 0.94
A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest (2007) 0.94
The singer's breath: implications for treatment of persons with emphysema. J Music Ther (2005) 0.92
Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: preliminary findings. Appl Psychophysiol Biofeedback (2004) 0.92
Effects of treatment on two types of self-efficacy in people with chronic obstructive pulmonary disease. J Pain Symptom Manage (2006) 0.91
Effects of specialized community nursing care in patients with chronic obstructive pulmonary disease. Heart Lung (1998) 0.91
End of life care in chronic obstructive pulmonary disease: in search of a good death. Int J Chron Obstruct Pulmon Dis (2008) 0.90
Exercise maintenance following pulmonary rehabilitation: effect of distractive stimuli. Chest (2002) 0.90
Efficacy of pursed-lips breathing: a breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev (2007) 0.89
Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs (2004) 0.89
Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease. Chest (1986) 0.89
The short-term effect of a rollator on functional exercise capacity among individuals with severe COPD. Chest (2002) 0.88
Effects of psychotherapy in moderately severe COPD: a pilot study. Eur Respir J (1997) 0.88
Psychosocial effects of continuous oxygen therapy in hypoxaemic chronic obstructive pulmonary disease patients. Eur Respir J (1989) 0.88
The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis (1988) 0.88
Factors associated with opioid dispensation for patients with COPD and lung cancer in the last year of life: A retrospective analysis. Int J Chron Obstruct Pulmon Dis (2010) 0.88
Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. J Cardiopulm Rehabil (1997) 0.87
Observational studies of a one year self-management program and a two year pulmonary rehabilitation program in patients with COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.85
The effects of guided imagery relaxation in people with COPD. Occup Ther Int (2004) 0.84
End-of-life care for COPD patients. Prim Care Respir J (2008) 0.84
Acupressure as an adjunct to a pulmonary rehabilitation program. J Cardiopulm Rehabil (1997) 0.84
Influence of spontaneous pursed lips breathing on walking endurance and oxygen saturation in patients with moderate to severe chronic obstructive pulmonary disease. Clin Rehabil (2008) 0.84
The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression. J Altern Complement Med (2007) 0.84
Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration (1993) 0.84
Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest (1993) 0.81
Patterns of domestic activity and ambulatory oxygen usage in COPD. Chest (2008) 0.81
Time course of expiratory flow limitation in COPD patients during acute respiratory failure requiring mechanical ventilation. Chest (2003) 0.81
Enhancement of exercise performance in COPD patients by hyperoxia: a call for research. Chest (2002) 0.80
Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch Intern Med (1986) 0.80
A review of quality of care evaluation for the palliation of dyspnea. Am J Respir Crit Care Med (2010) 0.80
Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest (2004) 0.80
Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 0.79
Effects of long-term oxygen therapy on quality of life and survival in chronic airflow limitation. Monaldi Arch Chest Dis (1999) 0.79
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ (2006) 5.70
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2007) 5.51
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J (2007) 4.27
Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med (2008) 4.12
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med (2008) 3.98
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67
An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med (2012) 3.62
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 3.61
Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med (2008) 3.48
Overdiagnosis of asthma in obese and nonobese adults. CMAJ (2008) 3.23
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. Can Respir J (2003) 3.14
Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study. Am J Respir Crit Care Med (2014) 2.46
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Mortality predictions in the intensive care unit: comparing physicians with scoring systems. Crit Care Med (2006) 2.29
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion. J Clin Oncol (2012) 2.28
Hypothesis: the research page. Participatory methods to facilitate research. Can Fam Physician (2002) 2.16
Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest (2005) 2.15
Incidence and risk factors for venous thromboembolic disease in podiatric surgery. Chest (2008) 2.09
An official American Thoracic Society workshop report: assessment and palliative management of dyspnea crisis. Ann Am Thorac Soc (2013) 2.08
Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07
Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest (2002) 2.02
Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.97
Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 1.97
Predictors of survival following in-hospital adult cardiopulmonary resuscitation. CMAJ (2002) 1.92
Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med (2008) 1.90
Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest (2002) 1.88
Heat stress in older individuals and patients with common chronic diseases. CMAJ (2009) 1.87
Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85
Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J (2011) 1.83
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82
Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med (2010) 1.80
Overdiagnosis of asthma in the community. Can Respir J (2004) 1.80
Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med (2009) 1.79
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76
Advanced chronic obstructive pulmonary disease: innovative approaches to palliation. J Palliat Med (2007) 1.74
A systematic review of satisfaction with care at the end of life. J Am Geriatr Soc (2007) 1.71
National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ (2006) 1.68
Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol (1985) (2007) 1.67
A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64
A Canadian, multicentre, randomized clinical trial of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: rationale and methods. Can Respir J (2005) 1.63
Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease. J Pain Symptom Manage (2011) 1.59
Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med (2013) 1.59
Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57
Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Can Respir J (2004) 1.55
Hypothesis: the research page. Participatory action research. Can Fam Physician (2002) 1.54
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.53
Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest (2006) 1.53
Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985) (2011) 1.53
Qualitative analysis of an intensive care unit family satisfaction survey. Crit Care Med (2011) 1.52
The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol (2014) 1.51
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res (2011) 1.51
Pain management principles in the critically ill. Chest (2009) 1.51
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care (2005) 1.50
Severe brain injury to neurological determination of death: Canadian forum recommendations. CMAJ (2006) 1.47
Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med (2002) 1.47
American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease. Chest (2010) 1.46
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer (2007) 1.45
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax (2007) 1.42
Enhancing the quality of end-of-life care in Canada. CMAJ (2013) 1.41
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control. J Med Chem (2009) 1.40
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
Prioritizing research at the Canadian Thoracic Society and beyond. Can Respir J (2010) 1.39
Influence of perceived functional and employment status on cardiopulmonary resuscitation directives. J Crit Care (2003) 1.39
Less smoke, more fire: What's new for you in the latest COPD guidelines? Can Fam Physician (2008) 1.38
Tracheal pressure regulated volume assist ventilation in acute respiratory failure. Can J Anaesth (2007) 1.38
Canadian Thoracic Society 2011 guideline update: diagnosis and treatment of sleep disordered breathing. Can Respir J (2011) 1.36
Evaluation of pain in ICU patients. Chest (2009) 1.36
State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. Can Respir J (2004) 1.35